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Available online 27 July 2014Abstract Sonic hedgehog (Shh) signaling is required for numerous developmental processes including specification of ven-
tral cell types in the central nervous system such as midbrain dopaminergic (DA) neurons. The multifunctional coreceptor Cdo
increases the signaling activity of Shh which is crucial for development of forebrain and neural tube. In this study, we
investigated the role of Cdo in midbrain DA neurogenesis. Cdo and Shh signaling components are induced during neurogenesis of
embryonic stem (ES) cells. Cdo−/− ES cells show reduced neuronal differentiation accompanied by increased cell death upon
neuronal induction. In addition, Cdo−/− ES cells form fewer tyrosine hydroxylase (TH) and microtubule associated protein 2
(MAP2)-positive DA neurons correlating with the decreased expression of key regulators of DA neurogenesis, such as Shh,
Neurogenin2, Mash1, Foxa2, Lmx1a, Nurr1 and Pitx3, relative to the Cdo+/+ ES cells. Consistently, the Cdo−/− embryonic
midbrain displays a reduction in expression of TH and Nurr1. Furthermore, activation of Shh signaling by treatment with
Purmorphamine (Pur) restores the DA neurogenesis of Cdo−/− ES cells, suggesting that Cdo is required for the full Shh signaling
activation to induce efficient DA neurogenesis.
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The promise of stem cell therapies in neurodegenerative
diseases such as Parkinson's disease has revived the pursuit
to gain insights into molecular mechanisms that regulate the
differentiation of stem/progenitor cells into specific neuro-
nal populations, such as midbrain dopaminergic (DA) neurons
(Barzilai and Melamed, 2003; Lang and Lozano, 1998;
Tzschentke and Schmidt, 2000). These DA neurons regulateaccess article under the CC BY-NC-ND license
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tion, and reward behaviors and their loss is associated with
Parkinson's disease. The DA neurons are first detected in the
ventral medial midbrain at embryonic day (E) 10.5 and their
generation is continued until E13.5 (Ono et al., 2007). The
development of DA neurons is a multi-step process from the
patterning of the mesencephalon, followed by specification
and differentiation of DA neuronal precursors to mature and
functional DA neurons. Each step is regulated in a complex
but coordinated fashion by cell-intrinsic and extrinsic soluble
factors [for review, see (Smits et al., 2006)]. Various solu-
ble factors such as, Sonic hedgehog (Shh), Fibroblast growth
factor 8 (FGF8), and Wnt1 have been shown to regulate
the initial stages of DA neuronal development to specify
DA progenitors in the medial ventral area of the midbrain
(Cooper et al., 2010; Yang et al., 2013). These extrinsic
signals control a number of key transcription factors such
as Neurogenin2 (Ngn2), Mash1, Foxa2, Lmx1a, Lmx1b, Nurr1,
and Pitx3 that are critical for various developmental stages
of DA neurogenesis (Andersson et al., 2006a,b; Ferri et al.,
2007; Kele et al., 2006; Martinat et al., 2006; Park et al.,
2006; Smidt et al., 2000). Among these extrinsic factors,
the spatio-temporal regulation of Shh signaling activities de-
fines multiple progenitor pools in the developing midbrain
(Joksimovic et al., 2009). Shh, expressed originally in the
notochord and successively in the floor plate, functions as a
ventral morphogenetic signal and regulates the generation
of DA neurons from the floor plate of themidbrain. Shh signaling
seems to initiate a cascade of transcription factors involved in
promoting early specification and differentiation of DA neurons
(Wu et al., 2012). Shh signaling has been reported to regulate
directly the expression of Foxa2 and Mash1, and indirectly Ngn2
and Nurr1 expression through Foxa2 thereby promoting DA
neurogenesis as well as regulating survival and maintenance of
DA neuronal progenitors in the ventral midbrain (Bae et al.,
2011; Lee et al., 2010; Lo et al., 2002; Sasaki et al., 1997;
Voronova et al., 2011). In addition, Ngn2 appears to be critical
for differentiation of DA progenitors into Nurr1-positive
postmitotic DA precursors (Thompson et al., 2006) and in turn
Nurr1 and Pitx3 promote the differentiation of DA precursors
into tyrosine hydroxylase-positive (TH+) DA neurons (Kim et al.,
2007). Thus the tight control of Shh signaling activation will be
critical to initiate this transcription factor cascade for efficient
DA neurogenesis.
The binding of Shh to its primary receptor Patched1 (Ptch1)
is regulated through signaling by a second mem-
brane component, Smoothened and the activation of Gli family
transcription factors which will turn on the downstream target
gene expression, such as Ptch1 and Gli1 (Bayly et al., 2007;
Fogel et al., 2008). The expression levels of Shh and its activities
are tightly regulated during embryonic development via
multiple mechanisms (Allen et al., 2011). Cdo, a member of
the immunoglobulin (Ig) superfamily, functions as a coreceptor
for Shh to induce full activation of Shh signaling together with
two other coreceptors, Boc and Gas1 (Bae et al., 2011; Kang et
al., 2007; Zhang et al., 2006a). During early development of the
CNS, Cdo is expressed in two regions important for patterning;
transiently in the prechordal plate and the notochord of the
developing CNS, and more persistently in the dorsal region of
the brain and the roof plate of the neural tube (Allen et al.,
2011; Zhang et al., 2011). Consistent with this expres-
sion pattern, Cdo-deficient mice exhibit multiple defects,including holoprosencephaly, hydrocephalus and reduced cor-
tical thickness (Zhang et al., 2006b, 2011). Based on our
previous studies, Cdo appears to regulate neurogenesis via two
independent pathways, p38MAPK and Shh signaling (Oh et al.,
2009; Tenzen et al., 2006; Zhang et al., 2006b). Cdo promotes
neurogenesis by activation of p38MAPK that can positively
regulate the activity of the neurogenic bHLH (basic helix–loop–
helix) factor, Ngn1 (Oh et al., 2009). In addition, Cdo-deficient
mice exhibit defects in ventral neural cell fate specification in
the neural tube and ventral forebrain in correlation with
decreased Shh signaling (Allen et al., 2011; Tenzen et al.,
2006; Zhang et al., 2006b). For full activation of Shh signaling,
the transient expression of Cdo in the prechordal mesoderm or
notochord appears to be critical to specify the ventral cell fates
in the ventral forebrain and neural tube (Tenzen et al., 2006;
Zhang et al., 2006b). Since Shh signaling is required for DA
neurogenesis and Cdo can promote neuronal differentiation via
activation of neural bHLH factors, we examined a potential role
of Cdo in DA neurogenesis. Several studies have shown the
usefulness of ES cell differentiation to investigate themolecular
regulatory mechanism of DA neurogenesis. In this study, we
utilize in vitro differentiation system of ES cells isolated from
Cdo+/+ and Cdo−/−mice to examine the role and molecular
mechanisms of Cdo in DA neurogenesis.
Materials and methods
Isolation of mouse embryonic fibroblasts (MEFs) and
ES cells, and cell cultures
MEFs were derived from days 12.5–13.5 post coitus fetuses
of strain ICR mice as previously described (Bae et al., 2011).
The second passage of MEFs was mitotically inactivated by
gamma irradiation and used as feeders for ES cells. To gen-
erate ES cells, blastocysts from intercrosses of Cdo+/−mutant
mice on a mixed 129SV/C57BL6 background were used.
Briefly, blastocysts were allowed to attach to MEFs on 0.1%
gelatin coated plates in ES cells growth medium [DMEM
supplemented with 15% FBS, 2 mM glutamate, 0.1 mM non-
essential amino acids, 20 mM HEPES (pH 7.3), 0.1 mM
β-mercaptoethanol, 1% gentamicine and LIF (1000 U/ml)]
for 3 days. The expanded inner cell mass cells were tryp-
sinized and seeded onto fresh feeder cells on 0.1% gelatin
coated plate. The culture media was replaced every second
day for several days after the first trypsinization. By appear-
ance of typical ES cell colonies, cells were trypsinized and
expanded. ES cells were routinely propagated on feeder
layers. We have established at least two independent ES cell
lines for each genotype and these ES cells exhibited normal
morphology and proliferation properties, compared to R1 ES
cells.
Monolayer differentiation of ES cells into neurons was
carried out as described previously (Oh et al., 2009; Ying et
al., 2003). To remove MEFs from the ES cell cultures, ES cells
were trypsinized for 5 min and plated on uncoated plates.
After 2 h, when most of the MEFs were attached to plates,
unattached ES cells were replated onto 0.1% gelatin-coated
plates at a density of 0.5–1.5 × 104/cm2 in the culture
medium with LIF for 24 h and cells were transferred into
the differentiation medium, DMEM/F12 plus N2/B27 sup-
plement containing vitamin A (Invitrogen) without LIF. The
264 Y.-R. Kwon et al.differentiation medium was replaced every second day
throughout 24 days of the differentiation time course. To
modulate Shh signaling activities, ES cells were treated
with Shh agonists, recombinant Shh with a concentration of
200 ng/ml (R&D systems), 2 mM Pur, or a Shh antagonist
10 μM SANT1 (Calbiochem) either for the first two days of
induction or for two days starting at D14 as indicated in the
figure legend.
RNA extraction, RT-PCR and real-time PCR analysis
Total RNA was extracted from cells using easyBLUE total
RNA extraction kit according to manufacturer's instructions
(Intron). The first strand of cDNA was synthesized from
0.5 μg of total RNA using Superscript II Reverse Transcriptase
(Invitrogen). RT-PCR reaction was done as previously de-
scribed (Bae et al., 2008), and quantification was performed
with Image-Gauge software (Fuji Film). The real-time PCR
reaction was carried out using a real-time PCR system with
the SYBR Green PCR master mix according to the
manufacturer's instructions (Invitrogen). The relative
amount of each transcript was normalized to Gapdh level.
All experiments were carried out as duplicates and repeated
at least twice. The forward (F) and reverse (R) primers used
in this study are listed below.Genes in Shh signaling:
Patched1 F; 5′-TTTTGGTTGTGGGTCTCCTC, R; 5′-TCC
ACCGTAAAGGAGGCTTA.
Gli1 F; 5′-GAAGGAATTCGTGTGCCATT, R; 5′-GGATC
TGTGTAGCGCTTGGT.
Cdo F; 5′-GTGTGCTTGGGGTTATGGTC, R; 5′-CTCCAT
TTATGTTTCCACTC.
Boc F; 5′-TGCTCTGGGTGTCTTCATCA, R; 5′-ATGGCA
TGATCAGGTAGTTG.
Gas1 F; 5′-GGAACACTGACCCACACTC, R; 5′-AAAGAC
CCCCACCGTTCAG.
Stemness genes:
Oct4 F; 5′-AAGCCCTCCCTACAGCAGAT, R; 5′-GGTGCCT
CAGTTTGAATGC.
Nanog F; 5′-GCTGCTCCGCTCCATAACTT, R; 5′-CTGGCT
TTGCCCTGACTTTA.
Sox2 F; 5′-CTGGAGTGGGAGGAAGAGGT, R; 5′-AACGG
CAGCTACAGCATGA.
Markers and regulators for neuronal differentiation:
β-tubulin III F; 5′-CAACGTCAAGGTAGCCGTGT, R; 5′-
TCCGATTCCTCGTCATCA TC.
MAP2 F; 5′-AGCCGCAACGCCAATGGATT, R; 5′-TTTGGT
CCGAGGCTGGCGAT.
NFM F; 5′-AGACCTTTGAGGAGAAGCTGG, R; 5′-TTCCCT
CATATTGCACAAAGG.
NeuroD F;5′-TGACCTTTCCCATGCTGAAT, R; 5′-AAGTG
CTAAGGCAACGCAAT.
Ngn2 F; 5′-GATGCCAAGCTCACGAAGAT, R; 5′-ACGTGG
AGTTGGAGGATGAC.
Mash1 F;5′-TAACTCCAAACCACTAACAGGC, R; 5′-TGAG
GAAAGACATCAACG CAGT.
TH F;5′-GCCGTCTCAGAGCAGGATAC, R; 5′-AGCATTTCC
ATCCCTCTCCT.
Lmx1a F;5′-ACGAACAGAACACCCAGAGG, R; 5′-ACCATA
GGGGTGCATGTGAT.Nurr1 F;5′-CGGTTTCAGAAGTGCCTAGC, R; 5′-TTGCCT
GGAACCTGGAATAG.
Pitx3 F;5′-GAGGACGGCTCTCTGAAGAA, R; 5′-CTCAGT
GAGGTTGGTCCACA.
FoxA2 F;5′-GGCACCTTGAGAAAGCAGTC, R; 5′-GACATA
CCGACGCAGCTACA.
Olig2 F;5′-CTGGTGTCTAGTCGCCCATC, R; 5′-AGGAGGT
GCTGGAGGAAGAT.
Nestin F;5′-CCAGAGCTGGACTGGAACTC, R; 5′-ACCTGC
CTCTTTTGGTTCCT.
GFAP F; 5′-CACGAACGAGTCCCTAGAGC, R; 5′-ATGGTG
ATGCGGTTTTCTTC.
Immunocytochemistry and microscopy
Immunostaining was carried out as described previously
(Oh et al., 2009; Lee et al., 2012; Takaesu et al., 2006).
The primary antibodies used in this study are as follows:
β-tubulin III (1:200; Sigma-Aldrich), MAP2 (1:200; Cell sig-
naling), Nestin (1:200; Invitrogen), TH (1:200; Invitrogen),
Alexa Fluor 568-Phalloidin (1:400; Invitrogen), and BrdU
(1:200; Chemicon). Immunofluorescent images were obtain-
ed either with a Nikon ECLIPS TE-2000U microscope and
NIS-Elements F software (Nikon) or with Zeiss LSM-510 Meta
confocal and Axiophot2 fluorescence microscopes were used
for imaging and measurement of neurite at SKKU School of
Medicine-Microscopy Shared Resource Facility. Quantifica-
tion of the percentage of differentiated Cdo+/+ and Cdo−/− ES
cells/colonies that possess neurites, and positive for β-tubulin
III, Nestin or MAP2 were counted and plotted. More than 6
fields and at least 200 cells/field or 10 colonies/field were
counted. Quantification of TH and MAP2-double positive
colonies relative to total colonies is plotted as percentile.
More than 5 fields and at least 10 colonies/field were counted.
TUNEL assay and BrdU incorporation
To monitor cell death, Cdo+/+ and Cdo−/− ES cells from dif-
ferentiation day 2 were fixed with 4% PFA followed by the
terminal deoxynucleotidyl transferase-dUTP nick end label-
ing (TUNEL) according to the manufacturer's instructions
(Invitrogen). To monitor cell proliferation, cells were grown
with bromodeoxyuridine (BrdU; Sigma-Aldrich) for 5 min and
then fixed with 4% paraformaldehyde followed by treatment
with 2 N HCl for 30 min at 37 °C and neutralization with
0.1 M borate buffer (pH 8.5). Cells were then immunostained
as described above.
Mice, immunohistochemistry, whole mount in situ
hybridization, and β-galactosidase staining
All mouse work was carried out as previously described
(Zhang et al., 2006a, 2011). The heterozygous Cdo mutant
mice were maintained on a C57BL/6 background and this
study was reviewed and approved by the IACUC of SKKU
School of Medicine (SUSM). SUSM is an AAALAC International
accredited facility and abide by the ILAR guide. For Nurr1
(1:200; Abcam) and TH (1:200; Cell Signal) immunohisto-
chemistry, embryos at E13.5 were fixed with 4% parafor-
maldehyde overnight at 4 °C and cryoprotected through a
successive sucrose incubation followed by embedding in OCT
265Cdo/Shh signaling in dopaminergic neurogenesisand cryosectioning at 8 μm thickness. Immunohistochemis-
try was carried out as previously described (Zhang et al.,
2006b) with an exception of the antigen retrieval. For the
antigen retrieval, the tissues were treated with 10 μg/ml
proteinase K at 37 °C for 10 min. Whole mount in situ
hybridization of E9.5 embryos for Shh was carried out as
previously described (Zhang et al., 2006a,b). The stained
embryos were then embedded in paraffin, sectioned at
10 μm and stained with hematoxylin and eosin as previously
described (Zhang et al., 2011). Cdo mutant mice were crossed
with Ptch1+/tm1Mps mice to monitor the Ptch1-lacZ reporter
activity and the whole mount β-galactosidase staining is
carried out as previously described (Zhang et al., 2006a).
Statistical analysis
Statistical analyses of the results are expressed as means ± SE
from at least three independent experiments. Error bars rep-
resent means ± SE. For comparison between multiple groups,
statistical significance was tested by a Mann–Whitney U test
for 2 groups or Kruskal–Wallis test for over 3 groups using SPSS
(18.0 version; SPSS, Chicago, IL, USA).
Results
Cdo and Shh signaling are involved in neuronal
differentiation of ES cells
To examine the role of Cdo and Shh signaling in DA neu-
rogenesis, we utilized in vitro differentiation protocols for
mouse ES cell lines which allow differentiation into neurons.
To establish an effective in vitro differentiation protocol
we employed a well characterized R1 ES cell line. Fig. 1A
describes the in vitro differentiation protocol that we used
in this study for R1 ES cells as well as ES cells derived from
Cdo+/+ and Cdo−/− blastocysts. R1 ES cells of the indicated
differentiation time points were analyzed by immunostain-
ing for neuronal differentiation and the RT-PCR analysis
for expression of Shh signaling components (Cdo, Boc, Gas1,
Gli1 and Patched1) and a stemness gene, Oct4. At early
differentiation day 6 (D6), neuronal differentiation of these
cells was defined by β-tubulin III-positive cells containing
long neurites (Fig. 1B), and colonies were formed at middle
and late differentiation days (D14–D24) (Fig. 1G). RT-PCR
analysis revealed that the Shh signaling coreceptors, Cdo,
Boc and Gas1, and the primary receptor Patched 1 were
induced at D2, but the induction of Patched1 and Boc ex-
pression was more robust at D4 and the expression of these
genes was sustained until D8 when β-tubulin III-positive
neuronal precursors were observed (Figs. 1B and C). Gli1
expression was detected in proliferating ES cells and
decreased slightly starting at D6, and was not detected at
D16 (Figs. 1C, E and H). Currently the role of Gli1 in the
proliferation of ES cells is unknown. As predicted, Oct4 was
expressed at the highest level in pluripotent, proliferating
cells and decreased slowly during neuronal differentiation.
To examine the role of Cdo in neuronal differentiation of
ES cells, we have established two independent ES cell lines
from Cdo+/+ and Cdo−/− blastocysts, and Cdo+/+ ES cells were
used for positive control in place of R1 ES cells. An initial
analysis did not show any difference in their morphologicaland proliferative characteristics between Cdo+/+ and Cdo−/−
ES cells (Fig. 1L). To verify the differentiation potential of
newly established ES cells, Cdo+/+ ES cells were induced to
differentiate using the same differentiation protocol shown
in Fig. 1A and analyzed by RT-PCR. As shown in Figs. 1E and
H, the expression profile of the Shh signaling components,
Cdo, Boc, Gas1, Patched1, Gli1, and a stemness gene, Oct4
resembled that of R1 ES cells. Other stemness genes (Sox2 and
Nanog) were shown in similar expression pattern of Oct4.
Moreover, neuronal differentiation markers, microtubule-
associated protein 2 (MAP2), Neurofilament M (NFM), NeuroD,
TH, Olig2 and β-tubulin III were induced and shown similar
patterns (Figs. 1E and H). Neuronal differentiation and mor-
phological characteristics also did not show any difference
between R1, and Cdo+/+ ES cells (Figs. 1J and K).
Cdo is required for the neuronal differentiation of
ES cells
Next we analyzed the neuronal differentiation capacities
of Cdo+/+ and Cdo−/− ES cells. Cdo+/+ and Cdo−/− cells were
induced to differentiate for 6 days or 16 days followed by
immunostaining with antibodies recognizing β-tubulin III,
Nestin and MAP2, and Phalloidin staining for investigating the
distribution of F-actin in cells (Figs. 2A and B). At D6, Cdo+/+
ES cells exhibited clusters of cells with long neurites and a
strong immunoreaction to β-tubulin III, MAP2 or Nestin,
suggesting efficient differentiation into neuronal progenitor
cells. In contrast, Cdo−/− ES cells showed fewer cell clusters
positive for β-tubulin III, MAP2 or Nestin and signals were
generally weaker. At D16, most of the Cdo+/+ ES cell clusters
contained β-tubulin III and MAP2-positive neurons with very
long neurites, while Cdo−/− ES cells showed only few clusters
with β-tubulin III and MAP2-positive neuronal precursors,
suggesting impaired neuronal differentiation. We deter-
mined the proliferation rate by BrdU incorporation and cell
death by TUNEL staining at D2. Cdo+/+ and Cdo−/− ES cells
exhibited no significant difference in BrdU incorporation
(Fig. 2E). On the other hand, Cdo+/+ ES cells displayed 12 ±
3.0% of TUNEL-positive cells while Cdo−/− ES cells had 21 ±
1.4% in TUNEL-positive cells (Figs. 2C and D). These data
suggest that the deregulation of stemness genes during
differentiation and increased cell death upon differentiation
may contribute to impaired neuronal differentiation of
Cdo-deficient ES cells.
Cdo is required for the efficient DA neuronal
lineages of ES cells
We then examined the differentiation capability of Cdo+/+
and Cdo−/− ES cells into DA neurons. Cdo+/+ and Cdo−/− ES
cells were induced to differentiate for 24 days and immu-
nostained for the expression of TH, a DA neuronal marker,
and MAP2 followed by Dapi staining. As shown in Figs. 3A and
B, Cdo+/+ ES cells formed 34 ± 1.1% of clusters containing
double positive cells for TH and MAP2. In contrast, clusters
of Cdo−/− ES cells were generally smaller and only 18 ± 2.2%
of clusters contained double positive cells and the number of
TH-positive cells per cluster were fewer. To quantify this
decrease in DA neuronal differentiation, RNAs harvested
from ES cells at D24 were subjected to real-time PCR. The
Figure 1 Cdo and Shh signaling are induced during neuronal differentiation of ES cells. (A) The schematic representation of the
protocol used in this study. (B) R1 mouse ES cells are induced to differentiate by differentiation medium (N2/B27) containing Vitamin
A, and immunostained with a β-tubulin III antibody (a neuronal marker, green). Actin filaments (red) and nuclei were stained by each
Phalloidin and Dapi at the indicated early differentiation time points (D2–D8). Size bar = 100 μm. (C) RNAs isolated from R1 cells
cultured in growth medium (G) or differentiation medium (N2/B27) for the indicated days (G2–D8) were subjected to RT-PCR for the
expression of Cdo, Boc, Gas1 (Shh coreceptors), Gli1, Patched 1 (Shh targets), Oct4 (a stemness gene) and Gapdh as an internal
control. (D) Quantificational analysis of the experiment in panel C. The intensity of each band was quantified relative to Gapdh. The
experiment was repeated three times with similar results. (E) RNAs isolated from Cdo+/+ ES cells at various differentiation time points
were analyzed by RT-PCR for the expression of Shh signaling components (Cdo, Boc, Gas1, Gli1 and Patched1), stemness genes (Oct4,
Sox2 and Nanog), neuronal markers (MAP2, NFM and NeuroD) and Gapdh as an internal control. (F) Quantification of representative
experiment shown in panel E. The intensity of each band was quantified relative to Gapdh. The experiment was repeated three times
with similar results. (G) Immunostaining of R1 ESCs at the time points between 14 and 24 days with a β-tubulin III antibody, and actin
filaments and nuclei were stained by each Phalloidin and Dapi. Size bar = 100 μm. (H) Semi-quantitative RT-PCR analysis for expression
of Shh coreceptors and neuronal marker genes with RNAs isolated from R1 and Cdo+/+ ESCs at D16 and D24. (I) Quantification of the
experiment in panel H. The intensity of each band was quantified relative to Gapdh. The experiment was repeated three times with
similar results. (J) R1 and Cdo+/+ ESCs were immunostained with β-tubulin III and TH followed by differentiation for 24 days. Size bar =
100 μm. (K) Morphologies of R1 ESCs and established Cdo+/+ ESCs on MEF cells with LIF containing growth medium. Size bar = 50 μm.
(L) Photomicrographs of Cdo+/+ and Cdo−/− ESCs at various days during establishment. Blastocysts grown on MEF cells (upper panel),
hatched blastocysts (middle panel) and colonies at passage 3. Size bar = 25 μm.
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Figure 2 Cdo−/− ES cells display impaired neuronal differentiation. (A) Cdo+/+ and Cdo−/− ES cells were induced to differentiate into
neurons for 6 (D6) or 16 days (D16) and immunostained with antibodies recognizing β-tubulin III, Nestin, or MAP2, and actin filament
was stained with Phalloidin followed by Dapi staining. These experiments were repeated 3 times with similar results. Size bar =
100 μm. Cdo deficiency resulted in decreased DA neurogenesis. (B) Quantification of the percentage of differentiated Cdo+/+ and
Cdo−/− ES cells/colonies that possess neurites, and positive for β-tubulin III, Nestin or MAP2 were counted and plotted as described for
(A). More than 6 fields and at least 200 cells/field or 10 colonies/field were counted. Data are means ± SE (n = 4). *P b 0.01. (C) Cdo+/+
and Cdo−/− ES cells were induced to differentiate for 2 days and cell death was determined by TUNEL assays. Size bar = 100 μm.
(D) TUNEL-positive cells were quantified relative to total cells and plotted as percentile. Data are means ± SE of 4 independent
experiments. *P b 0.05. (E) Cdo+/+ and Cdo−/− ES cells at G and D2 were analyzed for BrdU incorporation. This experiment was repeated
three times with similar results. Data are means ± SE. NS; non-significant.
267Cdo/Shh signaling in dopaminergic neurogenesisexpression level of TH in Cdo−/− ES cells was reduced to 42%
of the control level (Fig. 3C). These data suggest that Cdo−/−
ES cells displayed reduced capabilities to differentiate into
DA neurons. To examine this defect in detail, the expression
of several key regulators of DA neurogenesis (Lmx1a, Nurr1,Pitx3, Ngn2, Mash1 and Foxa2) and Shh signaling components
(Shh, Gli1 and Patched1 (Ptch1)) was analyzed by real-time
PCR. As shown in Fig. 3D, Cdo−/− ES cells displayed a sub-
stantial decrease in all genes analyzed, relative to the Cdo+/+
ES cells. Next we harvested RNAs at the indicated time points
Figure 3 Cdo is required for DA neuronal lineages. (A) Immunostaining of Cdo+/+ and Cdo−/− ES cells at differentiation day 24 for TH
and MAP2. Size bar = 100 μm. (B) Quantification of TH and MAP2-double positive colonies relative to total colonies are plotted as
percentile. This experiment was repeated at least 3 times with similar results. Data are means ± SE. *P b 0.05. (C) The real-time PCR
analysis of ES cells at D24 for the TH expression. The RNA levels of the TH from Cdo+/+ and Cdo−/− ES cells were quantified and
normalized to levels in Cdo+/+ ES cells. This experiment was carried out as triplicate and repeated three times with similar results. Data
are means ± SE. *P b 0.01. (D) The real-time PCR analysis of ES cells at D24 for key regulators of DA neurogenesis (Lmx1a, Nurr1, Pitx3,
Ngn2, Mash1) and Shh signaling components (Shh, Gli1, Ptch1, Foxa2). The RNA level of each was normalized to a level in Cdo+/+ ES
cells. This experiment was performed in triplicate and repeated independently. Data are means ± SE (n = 4). *P b 0.01. (E, F) Cdo+/+
and Cd-−/− ES cells were induced to differentiate into neurons for a total of 24 days and total RNAs are harvested at the indicated
time points followed by real-time PCR for the expression of Ngn2, Mash1, Lmx1a, Nurr1, Pitx3 and Shh. The RNA level of each was
normalized to a level in the G (growth) stage of Cdo+/+ ES cells. This experiment was performed in triplicate and repeated inde-
pendently. Data are means ± SE (n = 3). *P b 0.01.
268 Y.-R. Kwon et al.from day 0 to day 24 of the differentiation time course
employed real-time PCR to determine the expression of
Ngn2, Mash1, Lmx1a, Nurr1, Pitx3 and Shh. As shown in
Fig. 3E, both Ngn2 and Mash1 were strongly induced at D16 in
Cdo+/+ ES cells and decreased at D24. In contrast, Cdo−/− ES
cells exhibited a different dynamic of the expression of thesegenes. Ngn2 and Mash1 were induced only slightly at D4 or
D6 and stayed relatively constant until D16 without the ro-
bust increase that was seen in the Cdo+/+ ES cells. In addition,
Cdo+/+ ES cells exhibited a dramatic increase in the ex-
pression of Lmx1a, Nurr1, Pitx3 and Shh at D16. At D24, the
level of Lmx1a and Nurr1 was further increased, while Pitx3
269Cdo/Shh signaling in dopaminergic neurogenesisand Shh were decreased (Figs. 3E and F). In contrast, we
failed to observe this dramatic increase for all 6 genes in
Cdo−/− ES cells at D16 and with the exception of Shh, theFigure 4 Cdo-deficient midbrain displays decreased Shh signaling
midbrains at E13.5 for the expression of Nurr1 and TH. Size bar = 100
cells (n = 4). Nurr1+ or TH+ cells from Cdo+/+ rostral region set to 10
difference in the number of Nurr1+ and TH+ cells between Cdo+/+ a
Ptch1-lacZ transgene in Cdo+/+ and Cdo−/− embryos at embryonic
(arrowed) in upper panels are shown in lower panels. (D) Wholemou
Shh expression and sections of embryos (middle panels) shown in
sectional plane. Size bar = 500 μm. The black boxed areas in the miother 5 genes were expressed with low levels at D24 (Figs. 3E
and F). These data suggest that Cdo-deficient ES cells fail to
differentiate efficiently into neural lineages.and DA neurogenesis. (A) Immunostaining of Cdo+/+ and Cdo−/−
μm. (B) Quantitation of the relative numbers of Nurr1+ and TH+
0%. Bars represent standard error (SE). * indicates a significant
nd Cdo−/− embryos. *P b 0.01. (C) Wholemount staining of the
day 9.5. Size bar = 500 μm. The black boxed midbrain areas
nt in situ hybridization of Cdo+/+ and Cdo−/− embryos at E9.5 for
the upper panels. The line in the upper panels indicates the
ddle panels are shown in the lower panels.
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As a next step we analyzed the role of Cdo in DA neurogenesis
in vivo. Cryosections of Cdo+/+ and Cdo−/− midbrains of em-
bryos at E13.5 were prepared and subjected to immuno-
staining with antibodies to Nurr1 and TH. As shown in Figs. 4A
and B, the Cdo−/− midbrain exhibited substantially reduced
expression of Nurr1 and TH proteins compared to the Cdo+/+
midbrain, suggesting that Cdo is required for midbrain DA
neuronal development. We have previously shown that Cdo
is required for full activation of Shh signaling in the early
developing ventral forebrain and neural tube (Allen et al.,
2011; Tenzen et al., 2006) however it is unknown whether
Cdo is required for Shh signaling in the ventral midbrain.
Therefore we examined the Shh signaling activities in the
developing midbrain of Cdo+/+ and Cdo−/− embryos at E9.5,
prior to the first appearance of TH-positive neurons. To
analyze the Shh signaling activity, we have utilized the
compound mutant carrying a Patched1-LacZ reporter trans-
gene and the Cdo mutation. The Patched1-LacZ activity was
detected throughout the ventral brain areas of Cdo+/+ and
Cdo−/− embryos at E9.5 (Fig. 4C). However the staining in-
tensity in the Cdo−/− midbrain was significantly reduced,
relative to that in the Cdo+/+ midbrain. In addition, Cdo+/+
and Cdo−/− embryos at E9.5 were subjected to wholemount
in situ hybridization for Shh expression. Consistently, the Shh
mRNA expression was also detected throughout the Cdo−/−
ventral brain area and in coronal sections of the midbrain but
showed a significant reduction in Shh mRNA levels, compared
to that of the Cdo+/+ embryos (Fig. 4D). Taken together,
these data suggest that Cdo is required for the full activation
of Shh signaling in the ventral midbrain.
Activation of Shh signaling restores DA neurogenesis
of Cdo-deficient ES cells
To verify whether Cdo is required for DA neurogenesis by
regulating Shh signaling, we treated cells with a Shh agonist or
an antagonist for the initial two days of differentiation or
between D14 and D16 during DA neurogenesis, as shown in
Fig. 5A. Our initial experiment suggested that early Shh
signaling seems to be important. Therefore, Cdo+/+ and Cdo−/−
ES cells were treated with an Shh antagonist SANT1 for 2 days
upon induction of differentiation and RNAs were harvested
at D24, followed by real-time PCR for key regulators of DA
neurogenesis (Fig. 5B). The levels of Shh, Foxa2, Lmx1a, Nurr1
and Pitx3 were affected by SANT1 treatment to variable
degrees. However among these genes Lmx1a expression was
most severely affected in Cdo+/+ ES cells. In agreement with
previous data, the control-treated Cdo−/− ES cells displayed
significantly reduced expression of these genes that were
further decreased by SANT1-treatment, except Lmx1a. These
data suggest that Shh signaling is required for the initia-
tion stage of neurogenesis. Thus we asked whether the
treatment with Pur, an agonist of Shh signaling independent
of the ligand-receptor action, can restore DA neurogenesis in
Cdo-deficient ES cells. To do so, ES cells were treated with the
vehicle DMSO or Pur for 2 days upon induction of differenti-
ation and cells were then subjected to immunostaining for TH
and MAP2 at D19 (Figs. 5C and D). Cdo+/+ ES cells treated withDMSO displayed differentiation capabilities with 49 ± 1.4% of
MAP2 positive clusters per field. Similar to the previous
results, the control DMSO treated Cdo−/− ES cells showed a
stark reduction in MAP2 and/or TH-positive clusters per field,
while the Pur-treatment of Cdo−/− ES cells resulted in 52 ±
6.2% of MAP2 and 8 ± 1.4% of MAP2/TH-positive clusters per
field which is similar to the control ES cells. However the
signal intensity for TH appears to be weaker than in control
ES cells. These data suggest that reactivation of Shh signaling
in Cdo−/− ES cells at the initial stage of neurogenesis can
restore the differentiation potential of Cdo−/− ES cells into DA
neurons. To analyze in detail, RNAs from Cdo+/+ and Cdo−/− ES
cells treated with DMSO or Pur were harvested at the various
time points indicated and analyzed by real-time PCR for the
expression of Shh and Foxa2 (Fig. 5E). Consistently, Shh was
strongly enhanced at D16 and this was decreased at D24 in
the control-treated Cdo+/+ ES cells. Cdo−/− ES cells treated
with Pur showed an increased expression of Shh at D16 and
D24, compared to control-treated Cdo−/− ES cells however the
increased levels were only roughly 60% of that in control-
treated Cdo+/+ ES cells at D24. The expression of Foxa2 was
induced strongly in control-treated Cdo+/+ ES cells however
the Pur-treated Cdo−/− ES cells showed a three-fold increase
of Foxa2 expression relative to the control-treated cells
thereby reaching 50% of that in the control-treated Cdo+/+
ES cells at D8 (Fig. 5E). In addition, we have assessed the
expression level of Lmx1a, Nurr1 and Pitx3 in these cells at
D24. The Pur-treated Cdo−/− ES cells exhibited an increase to
the level that is equivalent to the control ES cells (Fig. 5F).
Furthermore, Cdo−/− ES cells were treated with soluble Shh
proteins for the initial 2 days of differentiation or for two
days starting at D14. RNAs harvested at D24 were subjected
to real-time PCR. As shown in Fig. 5G, the expression of Shh,
Lmx1a, Nurr1 and Pitx3 was significantly increased in the
Shh-treated cells for the initial two days except Foxa2,
relative to the control cells, while Shh treatment at D14
was much less effective. Taken together, these data suggest
that Shh signaling activation at the initiation stage of neu-
ronal differentiation is critical for DA neurogenesis and Cdo is
required for full activation of Shh signaling at the critical
initiation step of DA neurogenesis.Discussion
The potential of ES cells to differentiate into DA neurons in
vitro offers a simplified model system to dissect the mech-
anisms of cell intrinsic and extrinsic factors in DA neuro-
genesis, compared to the complex mammalian CNS (Baizabal
and Covarrubias, 2009; Murry and Keller, 2008). Furthermore,
ES cell-derived DA neurons are an attractive therapeutic tool
to treat neurodegenerative diseases like Parkinson's disease
due to their great potential to proliferate and differentiate
(Kriks et al., 2011). Therefore, understanding the regulatory
mechanisms of ES cell differentiation is beneficial to es-
tablish more efficient protocols to generate DA neurons from
ES cells. Several soluble factors and overexpression of key
regulators by genetic manipulation have been used to in-
duce DA neuronal specification and differentiation of ES cells
(Bayly et al., 2007; Prakash and Wurst, 2006; Vernay et al.,
2005). Among these factors, Shh signaling has been proposed
to be required for DA neurogenesis and exogenous Shh is
Figure 5 Activation of Shh signaling by the treatment with agonists restores DA neurogenesis of Cdo-deficient ES cells. (A) The
schematic representation of protocols used in this study. The time period for the treatment with Shh, SANT1 and Pur is indicated.
(B) RNAs isolated from Cdo+/+ and Cdo−/− ES cells at D24 treated with either DMSO or 10 μM SANT1 for the initial 2 days were analyzed
by real-time PCR. The RNA level of each was normalized to a level in Cdo+/+ ES cells. Data are means ± SE, *P b 0.05 (C) Cdo+/+ and
Cdo−/− ES cells were treated with either DMSO (−Pur) or 2 mM Purmorphamine (+Pur) for the initial 2 days in a differentiation
medium for 19 days and immunostained for MAP2 and TH expression. Size bar = 100 μm. (D) Quantification of MAP2 or TH positive
colonies is plotted as percentile in the experiment shown in panel C. More than at least 5 fields were quantified. Data are means ± SE,
(n = 3) *P b 0.005 (E) RNAs obtained from Cdo+/+ and Cdo−/− ES cells at indicated differentiation time points, treated with DMSO or
Pur for the initial 2 days were analyzed by real-time PCR for the expression of Shh and Foxa2. The RNA level of each was normalized to
a level in the D2 (differentiation day 2) stage of Cdo+/+ ES cells. Data are means ± SE (n = 3). *P b 0.01. (F) Real-time PCR analysis of
Cdo+/+ and Cdo−/− ES cells at D24 by Pur for Lmx1a, Nurr1 and Pitx3. The RNA level of the Lmx1a was normalized to a level in Cdo+/+ ES
cells. Data are means ± SE (n = 3). *P b 0.01. (G) Cdo−/− ES cells were treated with 200 ng/ml soluble Shh protein either for the initial
2 days (D0) or for two days starting at D14, RNAs were obtained at D24 and subjected to real-time PCR. The RNA level of each was
normalized to a level in the D2 (differentiation day 2) stage of Cdo−/− ES cells. Data are means ± SE (n = 3). *P b 0.01.
271Cdo/Shh signaling in dopaminergic neurogenesisgenerally added to induce differentiation of ES cells into
DA neurons (Lindvall, 2012; Wu et al., 2012). In addition, a
number of studies have shown that DA neurogenesis of ES cells
in vitro appears to recapitulate the temporal process of DA
neuron development in vivo (Chung et al., 2009; Fasano
et al., 2010; Martinat et al., 2006). The molecular mechanism
of Cdo in specification of ventral cell types of the forebrain
and neural tube has been well characterized while its role inmidbrain DA neurogenesis was entirely unknown. We thus
utilized ES cells to assess the role of Cdo in DA neurogenesis
and Shh signaling in the embryonic midbrain. The present
study is the first to show that Cdo is required for the spec-
ification of DA neurons in the ventral midbrain through Shh
signaling. Recent studies have suggested that the responsive-
ness to Shh and the Shh expression domain in the ventral
midbrain alters dynamically during DA neurogenesis and the
272 Y.-R. Kwon et al.Shh expression domain expands laterally during DA neuronal
development, suggesting that the tight regulation of Shh
signaling activities is important for DA neurogenesis (Hayes
et al., 2013; Tang et al., 2013). In particular, a transient but
strong activation of Shh signaling from notochord is essential
for the floor plate induction at the early patterning stages
of embryos which will be crucial for DA neuron specifica-
tion (Ribes et al., 2010). In general, Cdo is excluded from the
ventral regions of the developing CNS, most likely through
inhibition by Shh signaling (Tenzen et al., 2006; Zhang et al.,
2006a). However one exception of this inhibition by Shh on
Cdo expression is the notochord at early embryonic devel-
opment and Shh originating from the notochord activates
Shh signaling in the floor plate (Jeong and Epstein, 2003).
Previously we have shown that Cdo is transiently expressed in
the prechordal plate and notochord throughout developing
CNS and this transient expression appears to be required for
the specification of the ventral cell types in the forebrain
and neural tube (Tenzen et al., 2006; Zhang et al., 2006a).
Consistent with this notion, Cdo is induced in ES cells at the
initial specification stages of DA neurogenesis coinciding with
Shh signaling activation. However a robust Shh expression is
observed later at day 16 of ES cell differentiation coinciding
with the expression of key regulators of DA neurogenesis, such
as Ngn2, Mash1, Lmx1a, Nurr1 and Pitx3. This robust increase
may reflect the expansion of the Shh-expressing domain into
the lateral region of the ventral midbrain where TH-positive
neurons will be generated. Since the defective DA neuro-
genesis of Cdo-deficient ES cells is corrected by activation of
Shh signaling by Pur as well as Shh treatment at the initial
specification stage, the reduction of Shh signaling activity
at the specification stage may be a major cause for reduced
DA neurogenesis in Cdo-deficient ES cells. This is further
supported by the decreased Shh activity and Shh expression
in the Cdo-deficient ventral midbrain correlating with the
decreased DA neurogenesis.
At early developmental stages, Foxa2 has been shown to
be a direct downstream target of Shh signaling. In addition,
Foxa2 is required for turning on Shh in the midbrain (Sasaki
et al., 1997). The current study shows that the expression of
Foxa2 is decreased in Cdo-deficient ES cells and the Pur
treatment leads to a significant increase of Foxa2 transcript
at D8 which precedes the increased expression of Shh at D16,
suggesting that Foxa2 may contribute to the expansion of
the Shh expression domain during DA neurogenesis. In accor-
dance with the current study, it has previously been re-
ported that Foxa2 expression in the medial region of the
neural tube is reduced in Cdo−/− embryos (Allen et al., 2011;
Tenzen et al., 2006) correlated with reduced Shh activation
in the floor plate of the neural tube. Since the function of
these coreceptors is to activate Shh signaling by increasing
the affinity of Shh to the primary receptor we added a high
concentration of Shh ligand in Cdo-deficient ES cell cultures
for 2 days at the initiation stage or at D14 to mimic the hike
of Shh expression seen in Cdo+/+ cells at D16. Consistently,
the exogenous Shh ligand at the early time point restored
the expression of Shh and key regulators of DA neurogenesis
in Cdo-deficient ES cells. Unexpected profiles of expression
of Lmx1a and Foxa2 in Cdo−/− treated with Shh agonist/
antagonist might be caused by the presence of other Shh
coreceptors (Figs. 5B and E). Previous studies have suggested
that Cdo, Boc and Gas1, three coreceptors of Shh signalinghave both specific and overlapping functions and they are
necessary for Shh activation in early embryos (Allen et al.,
2011). Boc and Gas1 are also expressed at the early stage of
DA neurogenesis in ES cell cultures suggesting that these
proteins may contribute to the rescue effect of added Shh
ligands on DA neurogenesis in Cdo-deficiency.Conclusions
Cdo expression is induced in the initiation stage of DA
neurogenesis of ES cells and Cdo deficiency leads to the
reduction of key regulators of DA neurogenesis correlating
with decreased Shh signaling activation. Furthermore reac-
tivation of Shh signaling at the initial stage restores DA
neurogenesis of Cdo-deficient ES cells, suggesting that Cdo
is required for DA neurogenesis via full activation of Shh
signaling. These findings further support the notion that Cdo
is required for the ventral cell type specification throughout
the CNS via activation of Shh signaling.Author contributions
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